Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 20/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 20/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 8/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3274522 | 0.92 | CYP3A4 (0.74) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL4180262 | 0.87 | CYP3A4 (0.73) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL1816215 | 0.87 | CYP3A4 (0.86) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL4170085 | 0.85 | CYP3A4 (0.83) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL6349099 | 0.85 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL5257853 | 0.84 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL14290065 | 0.84 | CYP3A4 (0.68) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL2368041 | 0.83 | CYP3A4 (0.68) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL20987023 | 0.83 | CYP3A4 (0.65) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL20986992 | 0.82 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215593-A1 | AN IMPROVED PROCESS FOR PREPARATION OF ZASTAPRAZAN | HETERO LABS LIMITED (IN) | 2025-10-16 | — | — | WO | disclosed |